From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine
International Journal of Molecular Sciences · 30.04.2025 · 26 (9) · 4271
DOI: 10.3390/ijms26094271 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.04.2025. Verfasst von Corneliu Toader und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Neuronal Plasticity, Neurodegenerative Diseases. Die Arbeit wurde bisher 170-mal zitiert (Crossref) und nennt 330 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy Carol Davila.
Abstract (Originalsprache)
The brain-derived neurotrophic factor (BDNF) has become one of the cornerstones of neuropathology, influencing synaptic plasticity, cognitive resilience, and neuronal survival. Apart from its molecular biology, BDNF is a powerful target for transformative benefit in precision medicine, leading to innovative therapeutic approaches for neurodegenerative and psychiatric diseases like Alzheimer’s disease (AD), Parkinson’s disease (PD), major depressive disorder (MDD), and post-traumatic stress disorder (PTSD). Nevertheless, clinical applicability is obstructed by hurdles in delivery, patient-specific diversity, and pleiotropic signaling. Here, we summarize findings in BDNF research, including its regulatory pathways and diagnostic/prognostic biomarkers and integrative therapeutic approaches. We describe innovative delivery systems, such as lipid nanoparticle-based mRNA therapies and CRISPR-dCas9-based epigenetic editing that bypass obstacles such as BBB (blood–brain barrier) and enzymatic degradation. The recent implementation of multiplex panels combining BDNF biodynamic indicators with tau and amyloid-β signaling markers showcases novel levels of specificity for both early detection and potential therapeutic monitoring. Humanized preclinical models like iPSC-derived neurons and organoids point to the key role of BDNF in neurodeveloping and neurodegenerative processes, paralleling advances in bridging preclinical observation and clinical environments. Moreover, novel therapeutic tools delivering TrkB activators or the implementation of AI-based dynamic care platforms enable tailored and scalable treatments. This review also aims to extend a framework used in the understanding of BDNF’s relevance to traditional neurodegenerative models by situating more recent work detailing BDNF’s actions in ischemic tissues and the gut–brain axis in the context of systemic health. Finally, we outline a roadmap for the incorporation of BDNF-centered therapies into worldwide healthcare, highlighting ethical issues, equity, and interdisciplinary decomposition. The therapeutic potential of BDNF heralds a new era in neuroscience and medicine, revolutionizing brain health and paving the way for the advancement of precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Department of Vascular Neurosurgery, National Institute of Neurology and Neurovascular Diseases, 077160 Bucharest, Romania.
- Puls Med Association, 051885 Bucharest, Romania.
- Department of Anatomy, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Neurosurgery Department, Sanador Clinical Hospital, 010991 Bucharest, Romania.
- Medical Section, Romanian Academy, 010071 Bucharest, Romania.
Förderung
- University of Medicine and Pharmacy Carol Davila
Zitieren
APA
Toader, C., Serban, M., Munteanu, O., Covache-Busuioc, R. A., Enyedi, M., Ciurea, A. V., & Tataru, C. P. (2025). From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine. International Journal of Molecular Sciences, 26(9), 4271. https://doi.org/10.3390/ijms26094271
Vancouver
Toader C, Serban M, Munteanu O, Covache-Busuioc RA, Enyedi M, Ciurea AV, et al. From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine. International Journal of Molecular Sciences. 2025;26(9):4271. doi:10.3390/ijms26094271
BibTeX
@article{Toader2025,
author = {Toader, Corneliu and Serban, Matei and Munteanu, Octavian and Covache-Busuioc, Razvan-Adrian and Enyedi, Mihaly and Ciurea, Alexandru Vlad and Tataru, Calin Petru},
title = {From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {9},
pages = {4271},
doi = {10.3390/ijms26094271}
}
EUVIMED